Literature DB >> 8626780

MKP-3, a novel cytosolic protein-tyrosine phosphatase that exemplifies a new class of mitogen-activated protein kinase phosphatase.

M Muda1, U Boschert, R Dickinson, J C Martinou, I Martinou, M Camps, W Schlegel, S Arkinstall.   

Abstract

MKP-1 (also known as CL100, 3CH134, Erp, and hVH-1) exemplifies a class of dual-specificity phosphatase able to reverse the activation of mitogen-activated protein (MAP) kinase family members by dephosphorylating critical tyrosine and threonine residues. We now report the cloning of MKP-3, a novel protein phosphatase that also suppresses MAP kinase activation state. The deduced amino acid sequence of MKP-3 is 36% identical to MKP-1 and contains the characteristic extended active-site sequence motif VXVHCXXGXSRSXTXXXAYLM (where X is any amino acid) as well as two N-terminal CH2 domains displaying homology to the cell cycle regulator Cdc25 phosphatase. When expressed in COS-7 cells, MKP-3 blocks both the phosphorylation and enzymatic activation of ERK2 by mitogens. Northern analysis reveals a single mRNA species of 2.7 kilobases with an expression pattern distinct from other dual-specificity phosphatases. MKP-3 is expressed in lung, heart, brain, and kidney, but not significantly in skeletal muscle or testis. In situ hybridization studies of MKP-3 in brain reveal enrichment within the CA1, CA3, and CA4 layers of the hippocampus. Metrazole-stimulated seizure activity triggers rapid (<1 h) but transient up-regulation of MKP-3 mRNA in the cortex, piriform cortex, and some amygdala nuclei. Metrazole stimulated similar regional up-regulation of MKP-1, although this was additionally induced within the thalamus. MKP-3 mRNA also undergoes powerful induction in PC12 cells after 3 h of nerve growth factor treatment. This response appears specific insofar as epidermal growth factor and dibutyryl cyclic AMP fail to induce significant MKP-3 expression. Subcellular localization of epitope-tagged MKP-3 in sympathetic neurons reveals expression in the cytosol with exclusion from the nucleus. Together, these observations indicate that MKP-3 is a novel dual-specificity phosphatase that displays a distinct tissue distribution, subcellular localization, and regulated expression, suggesting a unique function in controlling MAP kinase family members. Identification of a second partial cDNA clone (MKP-X) encoding the C-terminal 280 amino acids of an additional phosphatase that is 76% identical to MKP-3 suggests the existence of a distinct structurally homologous subfamily of MAP kinase phosphatases.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8626780     DOI: 10.1074/jbc.271.8.4319

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  93 in total

1.  Biochemical and biological functions of the N-terminal, noncatalytic domain of extracellular signal-regulated kinase 2.

Authors:  S T Eblen; A D Catling; M C Assanah; M J Weber
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

Review 2.  Mitogen-activated protein kinases: specific messages from ubiquitous messengers.

Authors:  H J Schaeffer; M J Weber
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

Review 3.  Pulling strings below the surface: hormone receptor signaling through inhibition of protein tyrosine phosphatases.

Authors:  X Espanel; S Wälchli; R P Gobert; M El Alama; M L Curchod; N Gullu-Isler; R Hooft van Huijsduijnen
Journal:  Endocrine       Date:  2001-06       Impact factor: 3.633

4.  The hepatitis E virus open reading frame 3 protein activates ERK through binding and inhibition of the MAPK phosphatase.

Authors:  Anindita Kar-Roy; Hasan Korkaya; Ruchi Oberoi; Sunil Kumar Lal; Shahid Jameel
Journal:  J Biol Chem       Date:  2004-04-19       Impact factor: 5.157

Review 5.  Modulation of protein kinase signaling cascades by palytoxin.

Authors:  Elizabeth V Wattenberg
Journal:  Toxicon       Date:  2010-11-09       Impact factor: 3.033

6.  Bidirectional signals transduced by DAPK-ERK interaction promote the apoptotic effect of DAPK.

Authors:  Chun-Hau Chen; Won-Jing Wang; Jean-Cheng Kuo; Hsiao-Chien Tsai; Jia-Ren Lin; Zee-Fen Chang; Ruey-Hwa Chen
Journal:  EMBO J       Date:  2004-12-16       Impact factor: 11.598

7.  The C.elegans MAPK phosphatase LIP-1 is required for the G(2)/M meiotic arrest of developing oocytes.

Authors:  Alex Hajnal; Thomas Berset
Journal:  EMBO J       Date:  2002-08-15       Impact factor: 11.598

Review 8.  Regulation of cardiac hypertrophy and remodeling through the dual-specificity MAPK phosphatases (DUSPs).

Authors:  Ruijie Liu; Jeffery D Molkentin
Journal:  J Mol Cell Cardiol       Date:  2016-08-27       Impact factor: 5.000

9.  Cisplatin-mediated activation of extracellular signal-regulated kinases 1/2 (ERK1/2) by inhibition of ERK1/2 phosphatases.

Authors:  Agata Gozdz; Aruna Vashishta; Katarzyna Kalita; Erzsebet Szatmari; Jing-Juan Zheng; Shigeo Tamiya; Nicholas A Delamere; Michal Hetman
Journal:  J Neurochem       Date:  2008-07-04       Impact factor: 5.372

10.  Enzymatic activity and substrate specificity of mitogen-activated protein kinase p38alpha in different phosphorylation states.

Authors:  Yuan-Yuan Zhang; Zi-Qing Mei; Jia-Wei Wu; Zhi-Xin Wang
Journal:  J Biol Chem       Date:  2008-07-31       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.